Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

Edwards Lifesciences Corporation (EW) Profit Margins

Over the twelve months to 2026-06-30, Edwards Lifesciences Corporation (EW) had gross margin 77.8%, operating margin 22.3%, net margin 15.4%, free cash flow margin 22.0%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

EWEdwards Lifesciences CorporationFollow EW — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
51.3B
P/E TTM
51.2
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 10 days
LineFY2010
Dec 10		FY2011
Dec 11		FY2012
Dec 12		FY2013
Dec 13		FY2014
Dec 14		FY2015
Dec 15		FY2016
Dec 16		FY2017
Dec 17		FY2018
Dec 18		FY2019
Dec 19		FY2020
Dec 20		FY2021
Dec 21		FY2022
Dec 22		FY2023
Dec 23		FY2024
Dec 24		FY2025
Dec 25		TTM
Jun 26		Trend
Gross margin71.8%70.8%74.2%74.7%73.1%75.2%73.1%74.5%74.8%74.4%75.4%76.1%83.8%80.5%79.5%78.0%77.8%
Operating margin————————20.1%26.4%20.5%32.3%33.6%26.1%25.3%20.8%22.3%
Net margin15.1%14.1%15.3%19.0%34.9%19.8%19.2%17.0%19.4%24.1%18.8%28.7%34.1%28.0%76.7%17.7%15.4%
FCF margin13.1%13.8%13.3%17.8%40.4%17.9%17.8%24.2%18.5%21.4%14.8%26.9%21.8%12.8%5.3%22.0%22.0%

USD billions · SEC XBRL

Edwards Lifesciences Corporation — questions

What is Edwards Lifesciences Corporation's gross margin?
77.8% over the twelve months to 2026-06-30.
What is Edwards Lifesciences Corporation's operating margin?
22.3% over the twelve months to 2026-06-30.
What is Edwards Lifesciences Corporation's net profit margin?
15.4% over the twelve months to 2026-06-30.

Every figure on this page comes from Edwards Lifesciences Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.